| Assay ID | Title | Year | Journal | Article |
|---|
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID388060 | Induction of apoptosis in human HCT 116 cells assessed as caspase 3 activation by HTS assay | 2008 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
| Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. |
| AID281703 | Induction of apoptosis in human T47D cells assessed as accumulation at S phase at 0.1 uM after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281706 | Induction of apoptosis in human T47D cells assessed as accumulation at G1 phase at 0.1 uM after 48 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281698 | Induction of apoptosis in human T47D cells assessed as caspase activation after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281702 | Induction of apoptosis in human T47D cells assessed as accumulation at G1 phase at 0.1 uM after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID255667 | Effective concentration against human non-small cell lung cancer H1299 cells inducing apoptosis activity was measured by using cell and caspase-based HTS assay | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. |
| AID388059 | Induction of apoptosis in human T47D cells assessed as caspase 3 activation by HTS assay | 2008 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
| Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. |
| AID281715 | Inhibition of tubulin polymerization | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281708 | Induction of apoptosis in human T47D cells assessed as accumulation at G2/M phase at 0.1 uM after 48 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281701 | Induction of apoptosis in human T47D cells assessed as accumulation at subG1 phase at 0.1 uM after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281704 | Induction of apoptosis in human T47D cells assessed as accumulation at G2/M phase at 0.1 uM after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID311523 | Induction of apoptosis in human T47D cells | 2007 | Bioorganic & medicinal chemistry, Dec-15, Volume: 15, Issue:24
| A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine. |
| AID281695 | Induction of caspase-mediated apoptosis in Jurkat cells at 0.1 uM after 24 hrs by nuclear fragmentation assay | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281707 | Induction of apoptosis in human T47D cells assessed as accumulation at S phase at 0.1 uM after 48 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281699 | Induction of apoptosis in human H1299 cells assessed as caspase activation after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281705 | Induction of apoptosis in human T47D cells assessed as accumulation at subG1 phase at 0.1 uM after 48 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID281700 | Induction of apoptosis in human DLD1 cells assessed as caspase activation after 24 hrs | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID388061 | Induction of apoptosis in human SNU398 cells assessed as caspase 3 activation by HTS assay | 2008 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
| Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. |
| AID281697 | Induction of apoptosis in Jurkat cells assessed as PARP cleavage at 2.5 uM | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. |
| AID300808 | Induction of apoptosis in human HL60 B cells | 2007 | Bioorganic & medicinal chemistry, Oct-01, Volume: 15, Issue:19
| Novel TOPP descriptors in 3D-QSAR analysis of apoptosis inducing 4-aryl-4H-chromenes: comparison versus other 2D- and 3D-descriptors. |
| AID255664 | Effective concentration against human breast cancer T47D cell line inducing apoptosis activity was measured by cell and caspase-based HTS assay | 2005 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 15, Issue:21
| Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |